Dudediligence.

Celldex Therapeutics, Inc

CLDXNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$1,304,386

2 notices · 53,464 sh

Oct 2025 to Oct 2026

Reported ·

$1,304,383

2 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 2 reported sales carry the 10b5-1 box. Together they are 0.07% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2025-12-04: FREDDY A JIMENEZ, Form 1442025-11-13: RICHARD M WRIGHT, Form 1442025-11-13: Wright Richard M., sold2025-12-04: Jimenez Freddy A., sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2025-12-04FREDDY A JIMENEZ, SVP & GENERAL COUNSEL$121,210
4,166 shno plan date144 ↗
Form 4, 2025-12-08: sold 4,166 at $29.10 Form 4 ↗
2025-11-13RICHARD M WRIGHT, Officer$1,183,177
49,298 shno plan date144 ↗
Form 4, 2025-11-17: sold 49,298 at $24.00 Form 4 ↗